SNDX
Syndax Pharmaceuticals Inc
Price:  
13.12 
USD
Volume:  
1,248,449.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SNDX WACC - Weighted Average Cost of Capital

The WACC of Syndax Pharmaceuticals Inc (SNDX) is 6.6%.

The Cost of Equity of Syndax Pharmaceuticals Inc (SNDX) is 7.45%.
The Cost of Debt of Syndax Pharmaceuticals Inc (SNDX) is 5.00%.

Range Selected
Cost of equity 5.90% - 9.00% 7.45%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.4% - 7.8% 6.6%
WACC

SNDX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.45 0.75
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.90% 9.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.31 0.31
Cost of debt 5.00% 5.00%
After-tax WACC 5.4% 7.8%
Selected WACC 6.6%